Kayne Anderson Rudnick Investment Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $325 | Hold |
21
| – | – | ﹤0.01% | 1027 |
|
|
2025
Q1 | $312 | Hold |
21
| – | – | ﹤0.01% | 926 |
|
|
2024
Q4 | $278 | Sell |
21
-88
| -81% | -$1.17K | ﹤0.01% | 963 |
|
|
2024
Q3 | $1.55K | Sell |
109
-585,734
| -100% | -$8.33M | ﹤0.01% | 840 |
|
|
2024
Q2 | $7.58M | Sell |
585,843
-14,069
| -2% | -$182K | 0.02% | 258 |
|
|
2024
Q1 | $8.33M | Buy |
599,912
+1,788
| +0.3% | +$24.8K | 0.02% | 257 |
|
|
2023
Q4 | $8.54M | Buy |
598,124
+140,463
| +31% | +$2M | 0.02% | 258 |
|
|
2023
Q3 | $7.08M | Sell |
457,661
-22,427
| -5% | -$347K | 0.02% | 270 |
|
|
2023
Q2 | $7.54M | Buy |
480,088
+6,809
| +1% | +$107K | 0.02% | 269 |
|
|
2023
Q1 | $7.8M | Buy |
+473,279
| New | +$7.8M | 0.02% | 263 |
|
|
2022
Q2 | – | Sell |
-108
| Closed | -$2K | – | 680 |
|
|
2022
Q1 | $2K | Buy |
+108
| New | +$2K | ﹤0.01% | 605 |
|